(688046)"GEMPHARMATECH CO., LTD."Announcement on Departure of Key Technician
Filed with SSE · Stock code 688046 · · 3 pages · Chinese
Summary by 6ix AI
The company confirmed that her departure will not adversely affect ongoing research and development projects or the company's core competencies. Ms. Liang's responsibilities have been successfully transitioned, and she has fulfilled her confidentiality and non-compete obligations.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
GemPharmatech Co., Ltd. on 6ix
Story so far
- (688046)"GEMPHARMATECH CO., LTD."Announcement on Acquisition of 80% Equity Interest in Nanjing Bymybio Biotechnology Co., Ltd.
- (688046)"GEMPHARMATECH CO., LTD."Announcement on Completion of the Industrial and Commercial Registration Change and Issuance of a New Business License
- (688046)"GEMPHARMATECH CO., LTD."Announcement on Resolutions of the 2nd Meeting of the 3rd Board of Directors
Earlier from GemPharmatech
- (688046)"GEMPHARMATECH CO., LTD."Announcement on Acquisition of 80% Equity Interest in Nanjing Bymybio Biotechnology Co., Ltd.
- (688046)"GEMPHARMATECH CO., LTD."Report for Q3 2026
- (688046)"GEMPHARMATECH CO., LTD."Announcement on Resolutions of the 2nd Meeting of the 3rd Board of Directors
- (688046)"GEMPHARMATECH CO., LTD."Announcement on Provision for Asset Impairment for the First Three Quarters of 2026
- (688046)"GEMPHARMATECH CO., LTD."Announcement on Expiration of the Lock-up Period and Satisfaction of Unlocking Conditions for the Reserved Grant under the 2025 Employee Stock Ownership Plan
Follow GemPharmatech into a list and get an email when it puts out news.
Follow GemPharmatech